Syracuse

Testing individual and pooled saliva samples for sars-cov-2 nucleic acid: a prospective study

Archive ouverte

Migueres, Marion | Vellas, Camille | Abravanel, Florence | da Silva, Isabelle | Dimeglio, Chloé | Ferrer, Venicia | Raymond, Stéphanie | Mansuy, Jean-Michel | Izopet, Jacques

Edité par CCSD ; Elsevier -

International audience. Control of the rapid spread of the SARS-CoV-2 virus requires efficient testing. We collected paired nasopharyngeal swab (NPs) and saliva samples from 303 subjects (52.8% symptomatic) at a drive-through testing center; 18% of whom tested positive. The NPs, salivas and five saliva pools were tested for SARS-CoV-2 RNA using the Aptima™ assay and a laboratory-developed test (LDT) on the Panther-Fusion™ Hologic® platform. The saliva sensitivity was 80% (LDT) and 87.5% (Aptima™) whereas that of NPs was 96.4% in both assays. The pooled saliva sensitivity of 72.7% (LDT) and 75% (Aptima™) was not significantly different of that of individual saliva testing. Saliva specimens appear to be suitable for sensitive non-invasive assays to detect SARS-CoV-2 nucleic acid; pooling them for a single test will improve laboratory throughput.

• Description
• Sujet/Public
• Outil
• Outil d'anticipation
• Mémoire et thèse
• Gestion